Re:Cognition Chicago — Chicago, Illinois

Re:Cognition Chicago is a clinical research site located in Chicago, Illinois, United States 60611.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Re:Cognition Chicago has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Early Alzheimers Disease.

Sponsors: Annovis Bio Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Re:Cognition Chicago?

Re:Cognition Chicago has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Re:Cognition Chicago conducted?

Re:Cognition Chicago has 1 clinical trials on record, with 1 currently active. Their work covers Early Alzheimers Disease.

Is Re:Cognition Chicago accredited by Crixeo Clinical Trials?

Re:Cognition Chicago has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Re:Cognition Chicago?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.